Article
Polymorphisms in the GCK gene increase the risk of clopidogrel resistance in stable coronary artery disease (SCAD) patients.
Hematology (Amsterdam, Netherlands) - 1 Dec 2021
Xu Hongyu, Yu Qinglin, Zhou Honglin, Yang Jin, Zheng Nan, Xu Zhifeng, Su Jia
Abstract excerpt
BACKGROUND: Diabetes mellitus is a major factor in clopidogrel resistance (CR), and the glucokinase (GCK) gene plays a pivotal role in glucose homeostasis. This study investigated the contribution of GCK polymorphisms to CR risk. METHODS: Two hundred SCAD patients were recruited, and their platelet functions were detected by the Verify-Now P2Y12 assay. The polymorphisms of GCK were tested based on the methods of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
